CEO Àλ縻
 
 
 
 
 
HOME >°í°´Áö¿ø > °øÁö»çÇ×
   
  no
  °øÁö»çÇ×
  ´Ù¿î·Îµå
  ÀÚÀ¯°Ô½ÃÆÇ
  no
 
   
 
 
     
 
À̸§ °ü¸®ÀÚ
³¯Â¥ 2023³â 03¿ù 15ÀÏ 15½Ã 52ºÐ 18ÃÊ
Á¦¸ñ [Ç¥ÁØÄÚµå]Àå³»¹Ì»ý¹° À¯Àüü ºÐ¼®[Stool] Ç¥ÁØÄÚµå Ãß°¡
[Ç¥ÁØÄÚµå]Àå³»¹Ì»ý¹° À¯Àüü ºÐ¼®[Stool] Ç¥ÁØÄÚµå Ãß°¡
1. Ç¥Áذ˻çÄڵ带 ´ÙÀ½°ú °°ÀÌ Ãß°¡ÇÏ¿´½À´Ï´Ù.
2. Àû¿ëÀϽà : 2023.3.15 Áï½ÃÀû¿ë

BZU2303151XX500 00 Àå³»¹Ì»ý¹° À¯Àüü ºÐ¼®[Stool]
BZU2303152XX500 00 Àû°Ë»ç_Àå³»¹Ì»ý¹° À¯Àüü ºÐ¼®[Stool]
BZU2303153XX500 00 Àå³»¹Ì»ý¹° À¯Àüü ºÐ¼®(ÇÁ·Î¸ð¼Ç)[Stool]
BZU2303154XX500 00 Àå³»¹Ì»ý¹° À¯Àüü ºÐ¼®(2°³¿ù)[Stool]
BZU2303155XX500 00 Àå³»¹Ì»ý¹° À¯Àüü ºÐ¼®(3°³¿ù)[Stool]
BZU2303156XX500 00 Àå³»¹Ì»ý¹° À¯Àüü ºÐ¼®(6°³¿ù)[Stool]
BZU2303157XX500 00 Àå³»¹Ì»ý¹° À¯Àüü ºÐ¼®(12°³¿ù)-1[Stool]
BZU2303158XX500 00 Àå³»¹Ì»ý¹° À¯Àüü ºÐ¼®(12°³¿ù)-2[Stool]
BZU2303159XX500 00 ¿µÀ¯¾Æ Àå³»¹Ì»ý¹° À¯Àüü ºÐ¼®[Stool]
BZU2303151XX100 00 Ç÷Áß Áß±Ý¼Ó ¹× ¹Ì³×¶ö 13Á¾ °Ë»ç(trace element analysis)[Serum]
BZU2303152XX100 00 Ç÷Áß Áß±Ý¼Ó ¹× ¹Ì³×¶ö 13Á¾ °Ë»ç(ÃßÀû°üÂû)[Serum]
BZH0797XXXXX200 00 ¸¶½ºÅäüũ[WB(EDTA)]
 
  Total 377 Articles ( 7 / 38 )
¹øÈ£ Á¦¸ñ À̸§ ³¯Â¥ #
317  [Ç¥ÁØÄÚµå]CMV IgG Avidity[Serum] Ç¥ÁØÄÚµå Ãß°¡ °ü¸®ÀÚ23/06/090
316  [Ç¥ÁØÄÚµå]BioAge °í±ÞÇü[other] Ç¥ÁØÄÚµå Ãß°¡ °ü¸®ÀÚ23/05/310
315  [Ç¥ÁØÄÚµå]¸¶¾àÈ®Áø°Ë»ç1(Codeine+Morphine+6-Acetylm °ü¸®ÀÚ23/05/220
314  [Ç¥ÁØÄÚµå]Legionella pneumophila,PCR[Sputum] °ü¸®ÀÚ23/04/300
313  [Ç¥ÁØÄÚµå]¸é¿ªÁ¶Á÷È­Çп°»ö(CD56)[ÆÄ¶óÇÉblack] Ç¥ÁØÄÚµå Ãß°¡ °ü¸®ÀÚ23/04/200
312  [Ç¥ÁØÄÚµå]HPV Genotyping (Real-time PCR)[(Va °ü¸®ÀÚ23/04/070
311  [Ç¥ÁØÄÚµå]Arsenic (As)[Serum] Ç¥ÁØÄÚµå Ãß°¡ °ü¸®ÀÚ23/04/070
310  [Ç¥ÁØÄÚµå]Acute Leukemia immunophenotyping[W °ü¸®ÀÚ23/04/030
309  [Ç¥ÁØÄÚµå]¾Æ¿¬[Á߱ݼӿë±â(Serum)] Ç¥ÁØÄÚµå Ãß°¡ °ü¸®ÀÚ23/03/300
308  [Ç¥ÁØÄÚµå]Àå³»¹Ì»ý¹° À¯Àüü ºÐ¼®[Stool] Ç¥ÁØÄÚµå Ãß°¡ °ü¸®ÀÚ23/03/150
[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [Next 10°³]